Bausch Health Companies Inc. (BHC)
Makes pharmaceuticals, eye care products, and medical devices for digestive, skin, and vision health.
$4.48+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-21.5%
The outlook
BHC is trading well below its recent moving averages and near the bottom of its 52-week range, reflecting weak near-term momentum. Analysts are evenly split between positive and negative views, though the average price target sits about 63% above current levels. The overall sentiment leans bearish, suggesting investors remain cautious despite the significant gap between current price and consensus targets.
What’s behind the score
Analyst consensusHold — 3.0 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +63% vs current price
Analyst price target
~12-month · 5 analysts$7.30average target+62.9% vs now
Now $4.48
Low $5.50High $9.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.67B
52-wk high
$8.69
52-wk low
$4.33
50-day avg
$5.00
200-day avg
$5.86
Trailing P/E
—